Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Fredun Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Fredun Pharmaceuticals Ltd Share Price Chart
FREDUNPHARMA at 06 Feb 2026 04:06 PM Pharmaceuticals
1648.00 -16.75(-1.01%)
Lowest Today 1587.60
Highest Today 1665.00
Today's Open 1664.75
Prev. Close 1664.75
52 Week High 1999.00
52 Week Low 635.05
Fredun Pharmaceuticals Ltd Fundamentals
Traded Volume: 14,228
Market Cap(Cr): 884
Avg Traded Price 1634.70
1 Year return 120.81%
Upper Circuit 1,665
Lower Circuit 1,587.6
P/E TTM 0.00
P/B Ratio 5.559
Traded Value(Cr) 234.48
EPS TTM NaN
Book value/Share 299.470
Dividend Yield 1Y 0.00%
Fredun Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Fredun Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Fredun Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y +120.81%
YTD 0.00%
Fredun Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Fredun Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Fredun Pharmaceuticals Ltd Technical Details
Fredun Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1637
Support 2 1609
Support 3 1582
Pivot Point : 1663
Resistance 1 1691
Resistance 2 1718
Resistance 3 1746
Fredun Pharmaceuticals Ltd Corporate Actions
Fredun Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Fredun Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 23-Sep-2025 Type D Description 0.70/share@7.00% Record Date 23-Sep-2025 Ratio 7.00
Ex-Date 23-Sep-2024 Type D Description 0.70/share@7.00% Record Date 23-Sep-2024 Ratio 7.00
Ex-Date 22-Sep-2023 Type D Description 0.70/share@7.00% Record Date 22-Sep-2023 Ratio 7.00
Ex-Date 16-Sep-2021 Type D Description 0.70/share@7.00% Record Date 18-Sep-2021 Ratio 7.00
Ex-Date 16-Sep-2019 Type D Description 0.65/share@6.50% Record Date - Ratio 6.50
Ex-Date 18-Sep-2018 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 20-Sep-2017 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Ex-Date 11-Apr-2016 Type D Description 0.60/share@6.00% Record Date - Ratio 6.00
Dividends
Announcement Date 23-Sep-2025 Ex Dividend Date 23-Sep-2025 Dividend(%) 7
Announcement Date 23-Sep-2024 Ex Dividend Date 23-Sep-2024 Dividend(%) 7
Announcement Date 22-Sep-2023 Ex Dividend Date 22-Sep-2023 Dividend(%) 7
Announcement Date 16-Sep-2021 Ex Dividend Date 16-Sep-2021 Dividend(%) 7
Announcement Date 16-Sep-2019 Ex Dividend Date 16-Sep-2019 Dividend(%) 7
Announcement Date 18-Sep-2018 Ex Dividend Date 18-Sep-2018 Dividend(%) 6
Announcement Date 20-Sep-2017 Ex Dividend Date 20-Sep-2017 Dividend(%) 6
Announcement Date 11-Apr-2016 Ex Dividend Date 11-Apr-2016 Dividend(%) 6
Bonus
No Bonus has been declared by FREDUNPHARMA
Splits
No Split has been declared by FREDUNPHARMA
Others
Rights No Rights has been declared by FREDUNPHARMA
Fredun Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Fredun Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Fredun Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Anuh Pharma Ltd ₹79.30 (-0.60%) M. Cap (Cr) 7.95 1 Yr Return (%) -20.00% P/E (TTM) 20.64 PB Ratio 2.44
Stock Name Accent Microcell Ltd ₹330.00 (+2.26%) M. Cap (Cr) 7.92 1 Yr Return (%) +29.69% P/E (TTM) 23.94 PB Ratio 3.17
Stock Name Remus Pharmaceuticals Ltd ₹657.00 (-0.15%) M. Cap (Cr) 7.74 1 Yr Return (%) -36.45% P/E (TTM) 26.63 PB Ratio 2.52
Stock Name Fredun Pharmaceuticals Ltd ₹1648.00 (-1.01%) M. Cap (Cr) 8.84 1 Yr Return (%) +120.81% P/E (TTM) 26.92 PB Ratio 4.94
Stock Name Themis Medicare Ltd ₹83.68 (-0.70%) M. Cap (Cr) 7.71 1 Yr Return (%) -64.76% P/E (TTM) -28.57 PB Ratio 2.03
Stock Name Kopran Ltd ₹140.07 (-0.06%) M. Cap (Cr) 6.76 1 Yr Return (%) -22.06% P/E (TTM) 40.88 PB Ratio 1.35
Stock Name Bharat Parenterals Ltd ₹980.00 (+3.38%) M. Cap (Cr) 6.75 1 Yr Return (%) -24.32% P/E (TTM) -83.22 PB Ratio 2.04
Fredun Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Fredun Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -28.88 Mar 2024 -0.44 Mar 2023 -14.41 Mar 2022 -2.38 Mar 2021 0.17
PARTICULARS Investing Activities Mar 2025 -5.99 Mar 2024 -7.64 Mar 2023 -9.40 Mar 2022 -4.13 Mar 2021 -1.39
PARTICULARS Financing Activities Mar 2025 38.34 Mar 2024 5.99 Mar 2023 25.18 Mar 2022 7.47 Mar 2021 -0.71
PARTICULARS Net Cash Flow Mar 2025 3.47 Mar 2024 -2.08 Mar 2023 1.36 Mar 2022 0.96 Mar 2021 -1.93
Fredun Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Fredun Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Fredun Pharmaceuticals Ltd
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.In FY 2024, Company launched over 110 products under the Fredun Gx brand in India, including Anti-Diabetics, Anti-Hypertensives, Anti-biotics & Anti-fungal. During FY 2025 a second Italian Tube Filling Machine and two Automatic Carton Packaging Machines have been installed. Company acquired One Pet Stop Pvt Ltd, adding grooming services and access to over 4,000 pet owners. Fredun launched Freossi Tone+ (for lactation and milk quality) and Freossi Power (for joint health and mobility), targeting livestock like cows, buffaloes, horses, and cattle in 2025.
Chairperson & Joint MD
Daulat N Medhora
Registered office 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031
FAX :91-22-40318111
Background
Incorporation Year 1987
Face Value ₹10.00
Market Lot 1
FAQs on Fredun Pharmaceuticals Ltd
How to buy Fredun Pharmaceuticals Ltd shares on NSE?
To buy Fredun Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Fredun Pharmaceuticals Ltd share price today?
The Fredun Pharmaceuticals Ltd share price on NSE is ₹1648.00 today.
What is the market cap of Fredun Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹884.32.
What is the PE & PB ratio of Fredun Pharmaceuticals Ltd?
PE is N/A and PB is 5.559.
What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd shares?
Fredun Pharmaceuticals Ltd stock price high: ₹1999 Fredun Pharmaceuticals Ltd stock price low: ₹635.05.